Fukuoka, Kurume, Japan Clinical Trials

A listing of Fukuoka, Kurume, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 68 clinical trials
Safety and Pharmacokinetics of REGN2810 (Anti-PD-1) in Japanese Patients With Advanced Malignancies

The primary objective of the study is to assess the safety, tolerability, and Pharmacokinetics (PK) of REGN2810 in Japanese patients with advanced malignancies. The secondary objective of the study is to assess the immunogenicity of REGN2810.

ipilimumab
Kurume University Hospital
 (0.6 away) Contact site
  • 15 views
  • 24 Jan, 2021
  • +22 other locations
A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor

The primary purpose of the study is to evaluate safety and tolerability and to determine recommended Phase 2 dose (RP2D) of E7389-LF in combination with nivolumab in Phase 1b part, and to evaluate objective response rate (ORR) of E7389-LF and nivolumab using RP2D in Phase 2 part in each tumor …

Eisai Trial Site #4
 (0.0 away) Contact site
  • 2 views
  • 16 Jul, 2021
  • +17 other locations
ONO-4538 Phase II Rollover Study (ONO-4538-98)

This study is intended to confirm the long-term safety of ONO-4538 in pan-tumor participants being treated with ONO-4538 monotherapy in clinical trials.

Fukuoka Clinical Site1
 (0.0 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +14 other locations
A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) compared to placebo (PBO) as adjunctive treatment in subjects (>=16 to 80 years of age) with partial seizures with or without secondary generalization despite current treatment with 1 or 2 concomitant antiepileptic drugs (AEDs) and to assess …

brivaracetam
partial seizure
seizure
vagus nerve stimulation
antiepileptics
Ep0083 126
 (0.0 away) Contact site
  • 840 views
  • 16 Jul, 2021
  • +110 other locations
Study to Gather Information on Safety and Use of High Dose Aflibercept Injection Into the Eye in Patients With an Age Related Eye Disorder That Causes Blurred Vision or a Blind Spot Due to Abnormal Blood Vessels That Leak Fluid Into the Light Sensitive Lining Inside the Eye

In this study researchers want to learn more about changes in visual acuity (clarity of vision) with a high dose treatment with Aflibercept (Eylea) in patients suffering from neovascular age-related macular degeneration (nAMD). Neovascular AMD is an eye disease that causes blurred vision or a blind spot due to abnormal …

Kurume University Hospital
 (0.6 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +309 other locations
Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

The purpose of this study is to evaluate the efficacy and safety of MK-8189 at a range of doses (8 mg, 16 mg, and 24 mg once daily) in adult participants who have an acute episode of schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5) …

risperidone
National Hospital Organization Hizen Psychiatric Medical Center ( Site 2017)
 (7.3 away) Contact site
  • 0 views
  • 31 Jul, 2021
  • +63 other locations
The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries

The objective of this study is to verify the safety and efficacy of the investigational device (ELX1805J) for the treatment of ischemic heart disease due to de novo, native coronary artery lesions

bypass graft
percutaneous coronary intervention
coronary angioplasty
ischemia
heart disease
Shinkoga Hospital
 (0.9 away) Contact site
  • 0 views
  • 27 Jun, 2021
  • +35 other locations
Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.

The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of antiplatelet therapy in patients following a recent non cardioembolic ischemic stroke which occurs when a …

St.Mary's Hospital
 (1.0 away) Contact site
  • 45 views
  • 12 Jul, 2021
  • +261 other locations
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to assess the efficacy of etrasimod on clinical remission in participants with moderately to severely active ulcerative colitis (UC).

endoscopy
remission
Kurume University Hospital
 (0.6 away) Contact site
  • 12 views
  • 01 Aug, 2021
  • +438 other locations
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

The primary objective of the study is to determine if treatment with high-dose aflibercept (HD) at intervals of 12 or 16 weeks provides non-inferior best corrected visual acuity (BCVA) compared to aflibercept dosed every 8 weeks. The secondary objectives of the study are as follows: To determine the effect of …

retinopathy
corrected visual acuity
diabetic eye disease
visual impairment
diabetic macular edema
Regeneron Study Site
 (0.6 away) Contact site
  • 17 views
  • 14 May, 2021
  • +199 other locations